Kappa Delta Sorority - Gamma Kappa Chapter at UL Lafayette
Frontiers | Regulator of G-Protein Signaling (RGS) Protein Modulation of Opioid Receptor Signaling as a Potential Target for Pain Management
Deep learning guided optimization of human antibody against SARS-CoV-2 variants with broad neutralization | PNAS
Immune imprinting, breadth of variant recognition, and germinal center response in human SARS-CoV-2 infection and vaccination - ScienceDirect
Interaction Analysis of the Spike Protein of Delta and Omicron Variants of SARS-CoV-2 with hACE2 and Eight Monoclonal Antibodies Using the Fragment Molecular Orbital Method | Journal of Chemical Information and Modeling
Differential Interactions between Human ACE2 and Spike RBD of SARS-CoV-2 Variants of Concern | Journal of Chemical Theory and Computation
Elucidating the active δ-opioid receptor crystal structure with peptide and small-molecule agonists | Science Advances
Identification and differential usage of a host metalloproteinase entry pathway by SARS-CoV-2 Delta and Omicron - ScienceDirect
Viruses | Free Full-Text | Genomic Epidemiology of the SARS-CoV-2 Epidemic in Cyprus from November 2020 to October 2021: The Passage of Waves of Alpha and Delta Variants of Concern
Functional expression of opioid receptors and other human GPCRs in yeast engineered to produce human sterols | Nature Communications
Pathogenicity of SARS-CoV-2 Omicron (R346K) variant in Syrian hamsters and its cross-neutralization with different variants of concern - eBioMedicine
Platform for isolation and characterization of SARS-CoV-2 variants enables rapid characterization of Omicron in Australia | Nature Microbiology
Emerging SARS-CoV-2 variants of concern and potential intervention approaches | Critical Care | Full Text
SARS-CoV-2 prefusion spike protein stabilized by six rather than two prolines is more potent for inducing antibodies that neutralize viral variants of concern | PNAS
SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion | Nature
The G protein-first activation mechanism of opioid receptors by Gi protein and agonists | QRB Discovery | Cambridge Core
Cross-neutralization of SARS-CoV-2 Kappa and Delta variants by inactivated vaccine-elicited serum and monoclonal antibodies | Cell Discovery
Neutralization of the SARS-CoV-2 Mu Variant by Convalescent and Vaccine Serum | NEJM
Frontiers | Nanobodies Protecting From Lethal SARS-CoV-2 Infection Target Receptor Binding Epitopes Preserved in Virus Variants Other Than Omicron
Frontiers | SARS-CoV-2 Variants, Vaccines, and Host Immunity
IJERPH | Free Full-Text | Shorter Incubation Period among Unvaccinated Delta Variant Coronavirus Disease 2019 Patients in Japan
Structural basis for SARS-CoV-2 Delta variant recognition of ACE2 receptor and broadly neutralizing antibodies | Nature Communications
SARS-CoV-2 Beta and Delta variants trigger Fc effector function with increased cross-reactivity - ScienceDirect
Frontiers | Omicron: A Heavily Mutated SARS-CoV-2 Variant Exhibits Stronger Binding to ACE2 and Potently Escapes Approved COVID-19 Therapeutic Antibodies
The antigenicity of SARS-CoV-2 Delta variants aggregated 10 high-frequency mutations in RBD has not changed sufficiently to replace the current vaccine strain | Signal Transduction and Targeted Therapy
